4
Clinical Trials associated with WT1-W10 peptide vaccine(NEC Corp.)n exploratory trial of a WT1-W10 immunotherapy against pancreatic cancer in combination with the standard S1 chemotherapy. - n exploratory trial of a WT1-W10 immunotherapy against pancreatic cancer in combination with the standard S1 chemotherapy.
Start Date01 May 2016 |
Sponsor / Collaborator- |
A phase II study of WT1-W10 peptide vaccine monotherapy for patients with previously-treated advanced Non-Small Cell Lung Cancer - A phase II study of WT1 vaccine for previously-treated NSCLC
Start Date01 May 2014 |
Sponsor / Collaborator- |
A phase I/II study of Erlotinib plus WT1-W10 peptide vaccine for previously treated Non Small Cell Lung Cancer - A phase I/II study of Erlotinib plus WT1 vaccine for previously treated NSCLC
Start Date01 Dec 2012 |
Sponsor / Collaborator- |
100 Clinical Results associated with WT1-W10 peptide vaccine(NEC Corp.)
100 Translational Medicine associated with WT1-W10 peptide vaccine(NEC Corp.)
100 Patents (Medical) associated with WT1-W10 peptide vaccine(NEC Corp.)
100 Deals associated with WT1-W10 peptide vaccine(NEC Corp.)